Bayer AG

Bayer AG (https://www.bayer.de/) is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non.

• Bayer's farming business drives Q1 earnings beat (DE.BAYN) - 10 mai 2022
• Bayer (DE.BAYN) to invest 2 billion euros in drug production over next 3 years - 31 martie 2022
• Bayer (BAYN) anticipeaza profit operational in scadere - 28 februarie 2023

• Bayer AG
• O noua emisiune Fidelis - 07 august 2024
• Consum in scadere, productie in crestere - 08 martie 2024
• 3.6% din totalul investitiilor publice au venit din PNRR - 06 martie 2024
• Mai putini turisti - 05 martie 2024
• Listarea Maib impiedicata de cadrul legislativ - 21 februarie 2024
• SIF-urile, inceput slab la bursa - 13 februarie 2024
• Cel mai bun an din istoria pensiilor private si facultative - 30 ianuarie 2024
• Industria constructiilor s-a pozitionat mai sus in 2023 - 19 ianuarie 2024
• Numarul locurilor de munca vacante, in crestere - 21 noiembrie 2023